Lombard Odier Asset Management (Switzerland) Sa Vertex Pharmaceuticals Inc Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$976 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $864,302 - $945,689	-2,120 Reduced 5.87%	34,007 $14.2 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $5.74 Million - $6.87 Million	-16,729 Reduced 31.65%	36,127 $14.7 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $1.69 Million - $1.81 Million	-4,988 Reduced 8.62%	52,856 $18.4 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $3.26 Million - $3.65 Million	10,359 Added 21.82%	57,844 $20.4 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $12.7 Million - $14.5 Million	44,951 Added 1773.91%	47,485 $15 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $340,625 - $383,204	1,192 Added 88.82%	2,534 $731,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $370,218 - $413,076	-1,352 Reduced 50.19%	1,342 $389,000
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $632,982 - $788,129	2,694 New	2,694 $759,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $493,545 - $581,702	-2,229 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $394,555 - $498,070	2,229 New	2,229 $489,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $253,039 - $283,171	-1,395 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $50,059 - $59,033	-267 Reduced 16.06%	1,395 $281,000
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $344,067 - $401,057	1,662 New	1,662 $357,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $202,455 - $270,016	-978 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $250,025 - $296,431	978 New	978 $266,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $238,557 - $312,956	-1,058 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $176,379 - $236,896	1,058 New	1,058 $232,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account